Targeted Cytosolic Delivery of Cell-Impermeable Compounds by Nanoparticle-Mediated, Light-Triggered Endosome Disruption

Department of Cardiology, Howard Hughes Medical Institute, Manton Center for Orphan Disease, Children's Hospital Boston, Boston, Massachusetts 02115, USA.
Nano Letters (Impact Factor: 13.59). 06/2010; 10(6):2211-9. DOI: 10.1021/nl101157z
Source: PubMed


Nanoparticle (NP)-mediated drug delivery typically relies on cargo release to occur passively or in response to environmental stimuli. Here we present a delivery method based on light-activated disruption of intracellular vesicles after internalization of biofunctionalized mesoporous silica nanoparticles loaded with cargo. This method combines the power of targeted delivery with the spatiotemporal control of light activation. As an example, we delivered a cell-impermeable fluorescent compound exclusively to the cytosol of multidrug resistant cancer cells in a mixed population.

9 Reads
  • Source
    • "Most recently, researchers have utilized cell penetrating peptides [30,31], pH-dependent fusogenic peptides [32], as well as logic-embedded vectors [33] to achieve endosomal release after internalization. Others have minimized endosomal trapping by using silica [34], gold [35,36], and polymer-based nanoparticles [37] and polyactic acid [38], while yet others have disrupted endocytosis by using light-activated disruption of intracellular vesicles [39], or controlled sub-cellular damage of endosomal structures [40]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Nanotechnology-based bioassays that detect the presence and/or absence of a combination of cell markers are increasingly used to identify stem or progenitor cells, assess cell heterogeneity, and evaluate tumor malignancy and/or chemoresistance. Delivery methods that enable nanoparticles to rapidly detect emerging, intracellular markers within cell clusters of biopsies will greatly aid in tumor characterization, analysis of functional state and development of treatment regimens. Experiments utilized the Sendai virus to achieve in vitro, cytosolic delivery of Quantum dots in cells cultured from Human brain tumors. Using fluorescence microscopy and Transmission Electron Microscopy, in vitro experiments illustrated that these virus-based liposomes decreased the amount of non-specifically endocytosed nanoparticles by 50% in the Human glioblastoma and medulloblastoma samples studied. Significantly, virus-based liposome delivery also facilitated targeted binding of Quantum dots to cytosolic Epidermal Growth Factor Receptor within cultured cells, focal to the early detection and characterization of malignant brain tumors. These findings are the first to utilize the Sendai virus to achieve cytosolic, targeted intracellular binding of Qdots within Human brain tumor cells. The results are significant to the continued applicability of nanoparticles used for the molecular labeling of cancer cells to determine tumor heterogeneity, grade, and chemotherapeutic resistivity.
    Full-text · Article · Feb 2012 · Journal of Nanobiotechnology
  • [Show abstract] [Hide abstract]
    ABSTRACT: The AlGaAs/GaAs P-n-p heterojunction bipolar transistor (HBT) is shown by a simple analysis to exhibit millimeter wave and digital switching performance comparable to similar N-p-n structures. For example, a P-n-p HBT with a 1-µm emitter stripe and 34-µm2 total area yields fτ = 31 GHz, fmax= 94 GHz, and an intrinsic switching speed τs = 8 ps. A similar N-p-n structure exhibits fτ = 56 GHz, fmax= 102 GHz, and τS= 8 ps. Copyright © 1986 by The Institute of Electrical and Electronics Engineers, Inc.
    No preview · Article · Mar 1986 · IEEE Electron Device Letters
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Theranostics, the fusion of therapy and diagnostics for optimizing efficacy and safety of therapeutic regimes, is a growing field that is paving the way towards the goal of personalized medicine for the benefit of patients. The use of light as a remote-activation mechanism for drug delivery has received increased attention due to its advantages in highly specific spatial and temporal control of compound release. Photo-triggered theranostic constructs could facilitate an entirely new category of clinical solutions which permit early recognition of the disease by enhancing contrast in various imaging modalities followed by the tailored guidance of therapy. Finally, such theranostic agents could aid imaging modalities in monitoring response to therapy. This article reviews recent developments in the use of light-triggered theranostic agents for simultaneous imaging and photoactivation of therapeutic agents. Specifically, we discuss recent developments in the use of theranostic agents for photodynamic-, photothermal- or photo-triggered chemotherapy for several diseases.
    Full-text · Article · Aug 2010 · Advanced drug delivery reviews
Show more